cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA302718 | adipose tissue, white | .b | 3936 to 4210 | 275 to 1 | 275/275 (100 %) | 0 diff (100 %id) | |||
AA311309 | .b | 2505 to 2904 | 1 to 401 | 401/401 (100 %) | 1 diff (99.8 %id) | ||||
AA316015 | colon | .b | 3959 to 4206 | 1 to 248 | 248/248 (100 %) | 2 diff (99.2 %id) | |||
AB033095 | brain | .b | 51 to 4210 | 1 to 4160 | Q381P L382V | available from KIAA, | 4160/4160 (100 %) | 8 diff (99.9 %id) | |
AF173867 | .a | 1 to 2334 | 1 to 2334 | exact | tiling clone, AAA | 2334/2334 (100 %) | 5 diff (99.8 %id) | ||
AL117510 | testis | .b | 1548 to 4210 | 1 to 2663 | tiling clone, available from DKFZ, AAA | 2663/2663 (100 %) | 3 diff (99.9 %id) | ||
AL133646 | testis | .c | 1 to 4003 | 1 to 4003 | exact | tiling clone, available from DKFZ, AAA | 4003/4003 (100 %) | 5 diff (99.9 %id) | |
AW951958 | .b | 3922 to 4206 | 1 to 285 | AAA | 285/285 (100 %) | 0 diff (100 %id) | |||
BC036305 | Brain, adult medulla | .b | 1 to 1985 | 1 to 1985 | exact | tiling clone, available from MGC, AAA | 1985/1985 (100 %) | 4 diff (99.8 %id) | |
BE762315 | denis_drash | .b | 211 to 647 | 436 to 4 | tiling clone, | 433/440 (98 %) | 1 diff (99.8 %id) | ||
BF769731 | epid_tumor | .b | 2935 to 3140 | 1 to 206 | 206/206 (100 %) | 0 diff (100 %id) | |||
BG898255 | cartilage | .b | 1923 to 2353 | 82 to 512 | 431/444 (97 %) | 6 diff (98.7 %id) | |||
BI029200 | marrow | .b | 339 to 477 | 1 to 139 | 139/139 (100 %) | 1 diff (99.3 %id) | |||
BQ371652 | prostate_normal | .b | 3162 to 3444 | 285 to 2 | 284/287 (98 %) | 0 diff (100 %id) | |||
DA065317 | cerebellum | .b | 1984 to 2506 | 2 to 525 | capped | 524/524 (100 %) | 1 diff (99.9 %id) | ||
BU581295 | Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) | .b | 3687 to 4205 | 519 to 1 | 519/519 (100 %) | 1 diff (99.9 %id) | |||
BU581630 | Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) | .b | 3315 to 3814 | 1 to 500 | 500/500 (100 %) | 4 diff (99.2 %id) | |||
BX114046 | placenta | .b | 3356 to 4090 | 1 to 734 | 734/734 (100 %) | 1 diff (99.9 %id) | |||
CN356662 | embryonic stem cells, cell lines H1, H7, andH9 | .b | 1549 to 1686 | 1 to 138 | tiling clone, | 138/138 (100 %) | 0 diff (100 %id) | ||
CN356663 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .b | 657 to 977 | 1 to 321 | 321/321 (100 %) | 1 diff (99.7 %id) | |||
CN356664 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .b | 2931 to 3281 | 1 to 351 | 351/351 (100 %) | 2 diff (99.5 %id) | |||
CN356665 | embryonic stem cells, cell lines H1, H7, andH9 | .b | 3045 to 3710 | 1 to 666 | 666/666 (100 %) | 5 diff (99.3 %id) | |||
CN356666 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .b | 892 to 1588 | 1 to 698 | 698/698 (100 %) | 6 diff (99.2 %id) | |||
CR593931 | T cells (Jurkat cell line) Cot10-normalized | .b | 3521 to 4207 | 1 to 687 | 687/687 (100 %) | 0 diff (100 %id) | |||
BX341259 | .b | 3566 to 4171 | 606 to 1 | fully sequenced, | 606/606 (100 %) | 2 diff (99.7 %id) | |||
BX362352 | .b | 3521 to 4207 | 1 to 687 | fully sequenced, | 687/687 (100 %) | 2 diff (99.8 %id) | |||
CU456698 | epidermis | .d | 27 to 388 | 5 to 366 | tiling clone, | 362/366 (98 %) | 6 diff (98.4 %id) | ||
EC467859 | Prostate | .b | 4094 to 4202 | 109 to 3 | 107/111 (96 %) | 0 diff (100 %id) | |||
EC511506 | Prostate | .b | 4094 to 4202 | 110 to 3 | 108/112 (96 %) | 0 diff (100 %id) | |||
EC539686 | Prostate | .b | 4094 to 4195 | 112 to 11 | 102/114 (89 %) | 0 diff (100 %id) | |||
EC540252 | Prostate | .b | 4094 to 4202 | 108 to 3 | 106/110 (96 %) | 0 diff (100 %id) | |||
EC551413 | Prostate | .b | 4091 to 4196 | 114 to 11 | 104/114 (91 %) | 0 diff (100 %id) | |||
EH321246 | .b | 4129 to 4183 | 1 to 55 | 55/55 (100 %) | 0 diff (100 %id) | ||||
DA495436 | brain | .b | 1629 to 2154 | 2 to 531 | capped | 530/530 (100 %) | 5 diff (99.1 %id) | ||
DB474085 | hippocampus | .d | 683 to 1186 | 1 to 503 | tiling clone, | 503/503 (100 %) | 4 diff (99.3 %id) | ||
DB542886 | hippocampus | .b | 3713 to 4208 | 1 to 496 | Submitted on the opposite strand | 496/496 (100 %) | 0 diff (100 %id) | ||
T10712 | .b | 3941 to 4207 | 269 to 1 | 269/269 (100 %) | 12 diff (95.6 %id) | ||||
BP385983 | pancreatic islet | .b | 3653 to 4207 | 1 to 555 | Submitted on the opposite strand | 555/558 (99 %) | 1 diff (99.9 %id) | ||
BP419675 | small intestine | .d | 49 to 494 | 448 to 2 | 447/449 (99 %) | 0 diff (100 %id) | |||
BP424614 | small intestine | .d | 1 to 154 | 166 to 13 | tiling clone, | 154/166 (92 %) | 0 diff (100 %id) | ||
R68779 | placenta | .b | 3889 to 4195 | 318 to 2 | 317/368 (86 %) | 0 diff (100 %id) | |||
R68876 | placenta | .b | 3355 to 3785 | 1 to 442 | 442/442 (100 %) | 19 diff (95.8 %id) | |||
R82976 | breast | .b | 3764 to 4198 | 471 to 13 | 459/475 (96 %) | 0 diff (100 %id) | |||
H90393 | liver and spleen | .b | 3794 to 4175 | 388 to 1 | 388/389 (99 %) | 15 diff (96.2 %id) | |||
H90444 | liver and spleen | .b | 3395 to 3768 | 26 to 403 | 378/476 (79 %) | 10 diff (97.9 %id) | |||
N58893 | multiple sclerosis lesions | .b | 3831 to 4212 | 389 to 1 | fully sequenced, | 389/389 (100 %) | 10 diff (97.5 %id) | ||
N95565 | multiple sclerosis lesions | .b | 3568 to 3861 | 8 to 288 | fully sequenced, | 281/288 (97 %) | 8 diff (97.3 %id) | ||
N95457 | lung | .b | 3757 to 4207 | 426 to 1 | fully sequenced, | 426/426 (100 %) | 13 diff (97.0 %id) | ||
W25196 | lung | .b | 3470 to 3787 | 9 to 335 | fully sequenced, | 327/335 (97 %) | 7 diff (98.0 %id) | ||
AA706998 | liver and spleen | .b | 3762 to 4204 | 442 to 1 | 442/442 (100 %) | 8 diff (98.2 %id) | |||
AA045183 | uterus | .b | 3679 to 4207 | 547 to 6 | 542/548 (98 %) | 0 diff (100 %id) | |||
AA045545 | uterus | .b | 3794 to 4212 | 418 to 1 | fully sequenced, | 418/418 (100 %) | 12 diff (97.2 %id) | ||
AA056939 | uterus | .b | 3609 to 3824 | 1 to 215 | fully sequenced, | 215/215 (100 %) | 4 diff (98.2 %id) | ||
AA858275 | colon, colon tumor | .b | 3732 to 4207 | 478 to 4 | 475/481 (98 %) | 0 diff (100 %id) | |||
AA905631 | pooled | .f | 1 to 408 | 417 to 11 | G23W A24L P25Q S26A S28A ... | tiling clone, AAA | 407/407 (100 %) | 5 diff (98.8 %id) | |
AA918404 | Kidney | .b | 3734 to 4207 | 473 to 1 | 473/473 (100 %) | 4 diff (99.2 %id) | |||
AA975221 | pooled germ cell tumors | .b | 3765 to 4210 | 448 to 4 | 445/450 (98 %) | 0 diff (100 %id) | |||
AI243987 | Kidney | .b | 3997 to 4206 | 210 to 1 | 210/210 (100 %) | 0 diff (100 %id) | |||
AI298073 | carcinoid, lung | .b | 3797 to 4209 | 413 to 1 | 413/413 (100 %) | 0 diff (100 %id) | |||
AI309994 | 2 pooled tumors (clear cell type), Kidney | .b | 3276 to 3728 | 7 to 459 | Submitted on the opposite strand | 453/459 (98 %) | 6 diff (98.7 %id) | ||
AI337463 | lung | .d | 431 to 678 | 248 to 1 | 248/249 (99 %) | 5 diff (98.0 %id) | |||
AI338035 | uterus | .b | 3715 to 4210 | 503 to 8 | 496/503 (98 %) | 0 diff (100 %id) | |||
AI338145 | lung | .b | 3786 to 4207 | 422 to 1 | 422/422 (100 %) | 0 diff (100 %id) | |||
AI825860 | colon, colon tumor, RER+ | .b | 3777 to 4206 | 481 to 51 | AAA | 431/431 (100 %) | 25 diff (94.2 %id) | ||
AI687514 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .b | 4004 to 4206 | 203 to 1 | 203/203 (100 %) | 0 diff (100 %id) | |||
AI586985 | brain, tumor, 5 pooled (see description) | .b | 3952 to 4207 | 259 to 4 | 256/259 (98 %) | 0 diff (100 %id) | |||
AI696516 | carcinoid, lung | .b | 3915 to 4206 | 309 to 18 | AAA | 292/292 (100 %) | 2 diff (99.4 %id) | ||
AI796963 | carcinoid, lung | .b | 3987 to 4210 | 238 to 15 | AAA | 224/224 (100 %) | 2 diff (99.2 %id) | ||
AI808763 | pooled | .b | 133 to 313 | 1 to 181 | Submitted on the opposite strand | 181/181 (100 %) | 2 diff (98.9 %id) | ||
AI809929 | pooled | .e | 1 to 516 | 1 to 516 | exact | tiling clone, | Submitted on the opposite strand | 516/516 (100 %) | 0 diff (100 %id) |
AI910563 | pooled | .b | 3896 to 4207 | 313 to 1 | 313/313 (100 %) | 1 diff (99.7 %id) | |||
AI829941 | lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) | .b | 3701 to 4205 | 505 to 1 | 505/505 (100 %) | 3 diff (99.5 %id) | |||
AI989731 | colon, colonic mucosa from 3 patients with Crohn'sdisease | .b | 3817 to 4207 | 391 to 1 | 391/391 (100 %) | 0 diff (100 %id) | |||
AW005267 | thymus, pooled | .b | 1547 to 1987 | 447 to 7 | 441/447 (98 %) | 0 diff (100 %id) | |||
AW074904 | bone marrow, stem cell 34+/38+ | .b | 1870 to 1971 | 1 to 102 | Submitted on the opposite strand | 102/102 (100 %) | 6 diff (94.2 %id) | ||
AW085640 | esophagus, squamous cell carcinoma | .b | 3805 to 4206 | 426 to 25 | AAA | 402/402 (100 %) | 3 diff (99.3 %id) | ||
AW085114 | pooled | .b | 3874 to 4207 | 335 to 1 | 335/337 (99 %) | 6 diff (98.3 %id) | |||
AW572221 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .b | 3794 to 4207 | 414 to 1 | 414/414 (100 %) | 0 diff (100 %id) | |||
AW242570 | Kidney | .b | 3763 to 4207 | 457 to 1 | 457/457 (100 %) | 12 diff (97.4 %id) | |||
AW170418 | cervix, tumor | .b | 4095 to 4192 | 103 to 6 | 98/106 (92 %) | 0 diff (100 %id) | |||
AW241936 | pooled | .b | 26 to 588 | 1 to 563 | Submitted on the opposite strand | 563/576 (97 %) | 7 diff (98.8 %id) | ||
AW263625 | pooled | .b | 3766 to 4207 | 445 to 4 | 442/445 (99 %) | 0 diff (100 %id) | |||
AW195926 | pooled | .b | 3730 to 4207 | 481 to 3 | 479/481 (99 %) | 0 diff (100 %id) | |||
AW197805 | pooled | .b | 3867 to 4207 | 349 to 3 | 347/349 (99 %) | 0 diff (100 %id) | |||
AW512857 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .b | 3997 to 4206 | 210 to 1 | 210/210 (100 %) | 0 diff (100 %id) | |||
AW014755 | .b | 3690 to 4206 | 532 to 16 | AAA | 517/517 (100 %) | 0 diff (100 %id) | |||
AW015060 | .b | 3724 to 4206 | 498 to 16 | AAA | 483/483 (100 %) | 0 diff (100 %id) | |||
AW295083 | .b | 3810 to 4210 | 418 to 18 | AAA | 401/401 (100 %) | 2 diff (99.6 %id) | |||
AW271754 | Kidney | .b | 3858 to 4210 | 353 to 1 | 353/353 (100 %) | 0 diff (100 %id) | |||
AW612659 | carcinoid, lung | .b | 3707 to 4218 | 517 to 6 | tiling clone, | 512/519 (98 %) | 0 diff (100 %id) | ||
AW410603 | muscle, rhabdomyosarcoma | .b | 2187 to 2644 | 14 to 471 | 458/471 (97 %) | 6 diff (98.8 %id) | |||
AW410604 | muscle, rhabdomyosarcoma | .b | 3690 to 4210 | 546 to 26 | 521/546 (95 %) | 0 diff (100 %id) | |||
BF513044 | .d | 292 to 703 | 412 to 1 | tiling clone, | 412/412 (100 %) | 0 diff (100 %id) | |||
BE220210 | carcinoid, lung | .b | 3806 to 4210 | 419 to 15 | AAA | 405/405 (100 %) | 5 diff (98.8 %id) | ||
BE551413 | carcinoid, lung | .b | 3591 to 4146 | 1 to 557 | Submitted on the opposite strand | 557/557 (100 %) | 1 diff (99.9 %id) | ||
BE673184 | Prostate | .b | 3730 to 4212 | 500 to 18 | AAA | 483/483 (100 %) | 15 diff (96.9 %id) | ||
BE669667 | carcinoid, lung | .b | 3587 to 3923 | 1 to 337 | Submitted on the opposite strand | 337/337 (100 %) | 1 diff (99.8 %id) | ||
BE541492 | cervix | .b | 3356 to 4029 | 1 to 662 | 662/712 (92 %) | 14 diff (98.1 %id) | |||
BE513245 | adenocarcinoma cell line, colon | .b | 2755 to 3458 | 39 to 753 | 715/753 (94 %) | 7 diff (99.1 %id) | |||
BF435034 | fibrotheoma, ovary | .b | 3663 to 4214 | 553 to 2 | 552/553 (99 %) | 5 diff (99.1 %id) | |||
BE730950 | choriocarcinoma, placenta | .b | 1919 to 2712 | 1 to 784 | 784/808 (97 %) | 22 diff (97.3 %id) | |||
BE787704 | large cell carcinoma, lung | .b | 2118 to 2333 | 531 to 770 | 678/773 (87 %) | 49 diff (93.7 %id) | |||
BE904303 | epithelioid carcinoma, Pancreas | .b | 2287 to 2812 | 1 to 532 | 532/534 (99 %) | 18 diff (96.7 %id) | |||
BE799348 | lung, small cell carcinoma | .b | 2645 to 3476 | 34 to 863 | 830/977 (84 %) | 27 diff (97.3 %id) | |||
BF347431 | anaplastic oligodendroglioma with 1p/19qloss, brain | .b | 3843 to 4206 | 17 to 381 | AAA | 365/381 (95 %) | 6 diff (98.5 %id) | ||
BG109308 | Bone, osteosarcoma, cell line | .b | 3568 to 4207 | 22 to 658 | 637/673 (94 %) | 6 diff (99.2 %id) | |||
BG166761 | hypernephroma, cell line, Kidney | .b | 2845 to 3657 | 1 to 803 | 803/815 (98 %) | 24 diff (97.1 %id) | |||
BG342096 | B-cells, primary B-cells from tonsils (cell line) | .b | 2545 to 3292 | 1 to 750 | 750/825 (90 %) | 21 diff (97.5 %id) | |||
BG680655 | skin, squamous cell carcinoma | .b | 3149 to 4058 | 1 to 907 | tiling clone, | 907/908 (99 %) | 23 diff (97.5 %id) | ||
BG755401 | B-cells, primary B-cells from tonsils (cell line) | .b | 2545 to 3282 | 1 to 735 | 735/735 (100 %) | 6 diff (99.2 %id) | |||
BG755645 | B-cells, primary B-cells from tonsils (cell line) | .b | 2545 to 3233 | 1 to 687 | 687/687 (100 %) | 6 diff (99.2 %id) | |||
BG827191 | muscle, rhabdomyosarcoma | .b | 2870 to 2936 | 655 to 725 | 659/727 (90 %) | 47 diff (93.6 %id) | |||
BI261402 | lymph, lymphoma, cell line | .b | 2223 to 2819 | 1 to 598 | 598/600 (99 %) | 14 diff (97.7 %id) | |||
BI224414 | cervical carcinoma cell line, cervix | .b | 2889 to 3649 | 27 to 788 | 762/794 (95 %) | 38 diff (95.3 %id) | |||
BI254697 | cervical carcinoma cell line, cervix | .b | 2705 to 2834 | 1 to 130 | 130/130 (100 %) | 0 diff (100 %id) | |||
BI832207 | brain, medulla | .b | 6 to 585 | 26 to 601 | 576/601 (95 %) | 10 diff (98.4 %id) | |||
BI832170 | brain, medulla | .b | 24 to 731 | 1 to 709 | 709/709 (100 %) | 23 diff (96.8 %id) | |||
BI822092 | pooled brain, lung, testis | .b | 3458 to 4210 | 30 to 781 | 752/883 (85 %) | 4 diff (99.6 %id) | |||
BI855976 | breast, mammary adenocarcinoma, cell line | .b | 3571 to 4206 | 28 to 657 | AAA | 630/657 (95 %) | 6 diff (99.1 %id) | ||
BM006624 | ductal carcinoma, cell line, Pancreas | .b | 2277 to 3039 | 1 to 766 | 766/766 (100 %) | 11 diff (98.6 %id) | |||
BM460570 | leiomyosarcoma, uterus | .b | 1947 to 2671 | 1 to 728 | 728/1073 (67 %) | 21 diff (98.1 %id) | |||
BM875761 | insulinoma, Pancreas | .b | 3713 to 4132 | 8 to 427 | 420/428 (98 %) | 1 diff (99.8 %id) | |||
CK824013 | insulinoma, Pancreas | .b | 3713 to 4207 | 8 to 502 | 495/506 (97 %) | 2 diff (99.7 %id) | |||
BQ058444 | lymph, lymphoma, cell line | .b | 2225 to 3033 | 1 to 817 | 817/1073 (76 %) | 19 diff (98.3 %id) | |||
BQ059029 | lymph, lymphoma, cell line | .b | 2225 to 3252 | 1 to 1053 | 1053/1066 (98 %) | 53 diff (95.1 %id) | |||
BM999041 | lung, Lung Focal Fibrosis | .b | 3199 to 3678 | 499 to 19 | AAA | 481/481 (100 %) | 2 diff (99.6 %id) | ||
BQ015792 | lung, Metastatic Chondrosarcoma | .b | 3616 to 4210 | 613 to 19 | AAA | 595/595 (100 %) | 1 diff (99.9 %id) | ||
BQ691410 | ductal carcinoma, cell line, Pancreas | .b | 2278 to 3067 | 23 to 821 | 799/1002 (79 %) | 21 diff (98.0 %id) | |||
BQ686935 | ductal carcinoma, cell line, Pancreas | .b | 2280 to 3041 | 1 to 773 | 773/884 (87 %) | 29 diff (96.8 %id) | |||
BQ642416 | lymph, lymphoma, cell line | .b | 2225 to 3057 | 1 to 840 | 840/926 (90 %) | 13 diff (98.6 %id) | |||
BQ953056 | eye, normal pigmented retinal epithelium | .b | 2070 to 2982 | 1 to 919 | 919/921 (99 %) | 19 diff (98.0 %id) | |||
BQ923671 | eye, normal pigmented retinal epithelium | .b | 2070 to 2872 | 1 to 809 | 809/960 (84 %) | 10 diff (99.0 %id) | |||
BQ954281 | large cell carcinoma, lung | .b | 227 to 1128 | 1 to 904 | tiling clone, | 904/904 (100 %) | 12 diff (98.7 %id) | ||
CF454118 | peripheral nervous system | .b | 3068 to 3898 | 28 to 846 | 819/924 (88 %) | 16 diff (98.3 %id) | |||
CK000233 | mixed | .b | 2078 to 2839 | 7 to 768 | 762/768 (99 %) | 4 diff (99.5 %id) | |||
CK000857 | mixed | .b | 565 to 1280 | 1 to 715 | 715/791 (90 %) | 22 diff (97.3 %id) | |||
TI_57201845 | .b | 3458 to 4210 | 98 to 849 | AAA | 752/939 (80 %) | 4 diff (99.6 %id) | |||
TI_57172416 | .b | 6 to 585 | 26 to 601 | 576/601 (95 %) | 10 diff (98.4 %id) | ||||
TI_57175030 | .b | 24 to 731 | 1 to 709 | 709/709 (100 %) | 23 diff (96.8 %id) | ||||
TI_57186452 | .b | 3571 to 4206 | 83 to 712 | AAA | 630/630 (100 %) | 6 diff (99.1 %id) | |||
TI_59395367 | .b | 2278 to 3039 | 105 to 869 | 765/765 (100 %) | 10 diff (98.7 %id) | ||||
NM_012384.3 | .b | 1 to 4210 | 1 to 4210 | exact | RefSeq, | 4210/4210 (100 %) | 0 diff (100 %id) | ||
DA705846 | .d | 638 to 967 | 2 to 328 | capped | 327/327 (100 %) | 2 diff (99.4 %id) | |||
DA763976 | tongue | .b | 1994 to 2552 | 2 to 560 | capped | 559/559 (100 %) | 0 diff (100 %id) | ||
DA794960 | brain | .b | 1538 to 2014 | 2 to 479 | tiling clone, capped | 478/478 (100 %) | 2 diff (99.6 %id) | ||
DA818038 | .b | 1995 to 2549 | 2 to 557 | capped | 556/556 (100 %) | 2 diff (99.7 %id) | |||
BM840065 | lymph node, stomach | .b | 3767 to 4108 | 8 to 349 | 342/349 (97 %) | 6 diff (98.3 %id) | |||
BM841143 | lymph node, stomach | .b | 3767 to 4130 | 8 to 371 | 364/371 (98 %) | 6 diff (98.4 %id) | |||
DR006469 | Spleen | .d | 677 to 1300 | 1 to 625 | A80G E81* | tiling clone, | 625/625 (100 %) | 5 diff (99.2 %id) | |
TI_154033747 | .b | 3574 to 4210 | 82 to 717 | AAA | Submitted on the opposite strand | 636/717 (88 %) | 6 diff (99.2 %id) | ||
TI_154066874 | .b | 3757 to 4210 | 590 to 137 | 454/591 (76 %) | 0 diff (100 %id) | ||||
BQ026231 | placenta | .b | 3851 to 4206 | 371 to 16 | AAA | 356/356 (100 %) | 1 diff (99.8 %id) | ||
BQ022931 | placenta | .b | 3920 to 4206 | 303 to 17 | AAA | 287/287 (100 %) | 0 diff (100 %id) | ||
BM710168 | eye, optic nerve | .b | 3522 to 4037 | 1 to 516 | 516/516 (100 %) | 0 diff (100 %id) | |||
BM714673 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .b | 3696 to 4210 | 1 to 515 | AAA | 515/515 (100 %) | 0 diff (100 %id) | ||
BM725748 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .b | 3592 to 4107 | 1 to 516 | 516/516 (100 %) | 0 diff (100 %id) | |||
CA426405 | cell lines, Chondrosarcoma | .b | 3601 to 4206 | 622 to 17 | AAA | 606/606 (100 %) | 0 diff (100 %id) | ||
AK298927 | .b | 3458 to 4210 | 30 to 781 | Suspected internal deletion, this clone was ignored | 752/883 (85 %) | 4 diff (99.6 %id) | |||
DB311301 | thalamus | .b | 3571 to 4206 | 28 to 657 | Submitted on the opposite strand | 630/657 (95 %) | 6 diff (99.1 %id) | ||
CN356667 | embryonic stem cells, DMSO-treated H9 cellline | .b | 3571 to 4206 | 28 to 657 | Suspected internal deletion, this clone was ignored | 630/657 (95 %) | 6 diff (99.1 %id) | ||
AA837109 | germinal center B cell | .b | 2277 to 3039 | 1 to 766 | Suspected internal deletion, this clone was ignored | 766/766 (100 %) | 11 diff (98.6 %id) | ||
BM006624 | ductal carcinoma, cell line, Pancreas | .b | 2277 to 3039 | 1 to 766 | 766/766 (100 %) | 11 diff (98.6 %id) | |||
BM460570 | leiomyosarcoma, uterus | .b | 1947 to 2671 | 1 to 728 | 728/1073 (67 %) | 21 diff (98.1 %id) | |||
BM460570 | leiomyosarcoma, uterus | .b | 1947 to 2671 | 1 to 728 | 728/1073 (67 %) | 21 diff (98.1 %id) | |||
BM875761 | insulinoma, Pancreas | .b | 3713 to 4132 | 8 to 427 | 420/428 (98 %) | 1 diff (99.8 %id) | |||
BM875761 | insulinoma, Pancreas | .b | 3713 to 4132 | 8 to 427 | 420/428 (98 %) | 1 diff (99.8 %id) | |||
CK824013 | insulinoma, Pancreas | .b | 3713 to 4207 | 8 to 502 | 495/506 (97 %) | 2 diff (99.7 %id) | |||
CK824013 | insulinoma, Pancreas | .b | 3713 to 4207 | 8 to 502 | 495/506 (97 %) | 2 diff (99.7 %id) | |||
BQ058444 | lymph, lymphoma, cell line | .b | 2225 to 3033 | 1 to 817 | 817/1073 (76 %) | 19 diff (98.3 %id) | |||
BQ058444 | lymph, lymphoma, cell line | .b | 2225 to 3033 | 1 to 817 | 817/1073 (76 %) | 19 diff (98.3 %id) | |||
BQ059029 | lymph, lymphoma, cell line | .b | 2225 to 3252 | 1 to 1053 | 1053/1066 (98 %) | 53 diff (95.1 %id) | |||
BQ059029 | lymph, lymphoma, cell line | .b | 2225 to 3252 | 1 to 1053 | 1053/1066 (98 %) | 53 diff (95.1 %id) | |||
BM999041 | lung, Lung Focal Fibrosis | .b | 3199 to 3678 | 499 to 19 | AAA | 481/481 (100 %) | 2 diff (99.6 %id) | ||
BM999041 | lung, Lung Focal Fibrosis | .b | 3199 to 3678 | 499 to 19 | AAA | 481/481 (100 %) | 2 diff (99.6 %id) | ||
BQ015792 | lung, Metastatic Chondrosarcoma | .b | 3616 to 4210 | 613 to 19 | AAA | 595/595 (100 %) | 1 diff (99.9 %id) | ||
BQ015792 | lung, Metastatic Chondrosarcoma | .b | 3616 to 4210 | 613 to 19 | AAA | 595/595 (100 %) | 1 diff (99.9 %id) | ||
BQ691410 | ductal carcinoma, cell line, Pancreas | .b | 2278 to 3067 | 23 to 821 | 799/1002 (79 %) | 21 diff (98.0 %id) | |||
BQ691410 | ductal carcinoma, cell line, Pancreas | .b | 2278 to 3067 | 23 to 821 | 799/1002 (79 %) | 21 diff (98.0 %id) | |||
BQ686935 | ductal carcinoma, cell line, Pancreas | .b | 2280 to 3041 | 1 to 773 | 773/884 (87 %) | 29 diff (96.8 %id) | |||
BQ686935 | ductal carcinoma, cell line, Pancreas | .b | 2280 to 3041 | 1 to 773 | 773/884 (87 %) | 29 diff (96.8 %id) | |||
BQ642416 | lymph, lymphoma, cell line | .b | 2225 to 3057 | 1 to 840 | 840/926 (90 %) | 13 diff (98.6 %id) | |||
BQ642416 | lymph, lymphoma, cell line | .b | 2225 to 3057 | 1 to 840 | 840/926 (90 %) | 13 diff (98.6 %id) | |||
BQ953056 | eye, normal pigmented retinal epithelium | .b | 2070 to 2982 | 1 to 919 | 919/921 (99 %) | 19 diff (98.0 %id) | |||
BQ953056 | eye, normal pigmented retinal epithelium | .b | 2070 to 2982 | 1 to 919 | 919/921 (99 %) | 19 diff (98.0 %id) | |||
BQ923671 | eye, normal pigmented retinal epithelium | .b | 2070 to 2872 | 1 to 809 | 809/960 (84 %) | 10 diff (99.0 %id) | |||
BQ923671 | eye, normal pigmented retinal epithelium | .b | 2070 to 2872 | 1 to 809 | 809/960 (84 %) | 10 diff (99.0 %id) | |||
BQ954281 | large cell carcinoma, lung | .b | 227 to 1128 | 1 to 904 | tiling clone, | 904/904 (100 %) | 12 diff (98.7 %id) | ||
BQ954281 | large cell carcinoma, lung | .b | 227 to 1128 | 1 to 904 | tiling clone, | 904/904 (100 %) | 12 diff (98.7 %id) | ||
CF454118 | peripheral nervous system | .b | 3068 to 3898 | 28 to 846 | 819/924 (88 %) | 16 diff (98.3 %id) | |||
CK000233 | mixed | .b | 2078 to 2839 | 7 to 768 | 762/768 (99 %) | 4 diff (99.5 %id) | |||
CK000857 | mixed | .b | 565 to 1280 | 1 to 715 | 715/791 (90 %) | 22 diff (97.3 %id) | |||
TI_57201845 | .b | 3458 to 4210 | 98 to 849 | AAA | 752/939 (80 %) | 4 diff (99.6 %id) | |||
TI_57172416 | .b | 6 to 585 | 26 to 601 | 576/601 (95 %) | 10 diff (98.4 %id) | ||||
TI_57175030 | .b | 24 to 731 | 1 to 709 | 709/709 (100 %) | 23 diff (96.8 %id) | ||||
TI_57186452 | .b | 3571 to 4206 | 83 to 712 | AAA | 630/630 (100 %) | 6 diff (99.1 %id) | |||
TI_59395367 | .b | 2278 to 3039 | 105 to 869 | 765/765 (100 %) | 10 diff (98.7 %id) | ||||
NM_012384.3 | .b | 1 to 4210 | 1 to 4210 | exact | RefSeq, | 4210/4210 (100 %) | 0 diff (100 %id) | ||
DA705846 | .d | 638 to 967 | 2 to 328 | capped | 327/327 (100 %) | 2 diff (99.4 %id) | |||
DA763976 | tongue | .b | 1994 to 2552 | 2 to 560 | capped | 559/559 (100 %) | 0 diff (100 %id) | ||
DA794960 | brain | .b | 1538 to 2014 | 2 to 479 | tiling clone, capped | 478/478 (100 %) | 2 diff (99.6 %id) | ||
DA818038 | .b | 1995 to 2549 | 2 to 557 | capped | 556/556 (100 %) | 2 diff (99.7 %id) | |||
BM840065 | lymph node, stomach | .b | 3767 to 4108 | 8 to 349 | 342/349 (97 %) | 6 diff (98.3 %id) | |||
BM840065 | lymph node, stomach | .b | 3767 to 4108 | 8 to 349 | 342/349 (97 %) | 6 diff (98.3 %id) | |||
BM841143 | lymph node, stomach | .b | 3767 to 4130 | 8 to 371 | 364/371 (98 %) | 6 diff (98.4 %id) | |||
BM841143 | lymph node, stomach | .b | 3767 to 4130 | 8 to 371 | 364/371 (98 %) | 6 diff (98.4 %id) | |||
DR006469 | Spleen | .d | 677 to 1300 | 1 to 625 | A80G E81* | tiling clone, | 625/625 (100 %) | 5 diff (99.2 %id) | |
TI_154033747 | .b | 3574 to 4210 | 82 to 717 | AAA | Submitted on the opposite strand | 636/717 (88 %) | 6 diff (99.2 %id) | ||
TI_154066874 | .b | 3757 to 4210 | 590 to 137 | 454/591 (76 %) | 0 diff (100 %id) | ||||
BQ026231 | placenta | .b | 3851 to 4206 | 371 to 16 | AAA | 356/356 (100 %) | 1 diff (99.8 %id) | ||
BQ022931 | placenta | .b | 3920 to 4206 | 303 to 17 | AAA | 287/287 (100 %) | 0 diff (100 %id) | ||
BM710168 | eye, optic nerve | .b | 3522 to 4037 | 1 to 516 | 516/516 (100 %) | 0 diff (100 %id) | |||
BM710168 | eye, optic nerve | .b | 3522 to 4037 | 1 to 516 | 516/516 (100 %) | 0 diff (100 %id) | |||
BM714673 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .b | 3696 to 4210 | 1 to 515 | AAA | 515/515 (100 %) | 0 diff (100 %id) | ||
BM714673 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .b | 3696 to 4210 | 1 to 515 | AAA | 515/515 (100 %) | 0 diff (100 %id) | ||
BM725748 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .b | 3592 to 4107 | 1 to 516 | 516/516 (100 %) | 0 diff (100 %id) | |||
BM725748 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .b | 3592 to 4107 | 1 to 516 | 516/516 (100 %) | 0 diff (100 %id) | |||
CA426405 | cell lines, Chondrosarcoma | .b | 3601 to 4206 | 622 to 17 | AAA | 606/606 (100 %) | 0 diff (100 %id) | ||
CA426405 | cell lines, Chondrosarcoma | .b | 3601 to 4206 | 622 to 17 | AAA | 606/606 (100 %) | 0 diff (100 %id) |
? | Gene Summary | Gene on genome | mRNA:.a, .b, .c, .d, .e, .f | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes CI |